Suppr超能文献

三种培养基在黑素瘤细胞系建立中的比较。

Comparison of three culture media for the establishment of melanoma cell lines.

机构信息

Unit of Cell and Gene Therapy (UTCG), Nantes University Hospital/CHU de Nantes, 44093, Nantes, France.

出版信息

Cytotechnology. 2010 Oct;62(5):403-12. doi: 10.1007/s10616-010-9286-9. Epub 2010 Aug 21.

Abstract

Melanoma cell lines are useful tools for the analysis of tumor-specific lymphocytes which are injected to patients treated by adoptive immunotherapy. So they have been established previously (with an efficacy of 47%) in Roswell Park Memorial Institute (RPMI) medium enriched with fetal calf serum (FCS). In order to improve the probability of establishing melanoma cell lines, we compared two FCS-free media with the original FCS medium. Ten melanoma-invaded lymph nodes were tested for their ability to grow in three different culture media: RPMI with FCS; RPMI with human serum (HS); serum-free X-vivo 15 (X15). For each medium, we compared the following criteria: percentage of lines obtained; period of establishment; cell morphology; expression of melanoma-associated antigens and surface molecules. More cell lines were obtained with HS and X15 media compared to FCS medium (7/10, 5/10 and 4/10, respectively). The time period to establish a stable line was similar for the three media. No morphological differences were observed in cells derived from the same tumor sample in the different media. With the X15 medium, cells generally expressed lower levels of melanocytic differentiation antigens and surface molecules. The growth of melanoma cell lines in FCS-free culture media appears possible and advantageous, with an increased probability of obtaining autologous tumor cell lines. Furthermore the cells obtained could be used as multiple antigenic sources in active or adoptive immunotherapy protocols.

摘要

黑色素瘤细胞系是分析注入接受过过继免疫疗法治疗的患者的肿瘤特异性淋巴细胞的有用工具。因此,它们之前已经在富有人胎血清(FCS)的罗格斯大学癌症研究所(RPMI)培养基中建立(效力为 47%)。为了提高建立黑色素瘤细胞系的可能性,我们将两种无 FCS 培养基与原始 FCS 培养基进行了比较。对十个黑色素瘤浸润的淋巴结进行了测试,以评估它们在三种不同培养基中生长的能力:含 FCS 的 RPMI;含人血清(HS)的 RPMI;无血清 X-vivo 15(X15)。对于每种培养基,我们比较了以下标准:获得的细胞系的百分比;建立的时间;细胞形态;黑色素瘤相关抗原和表面分子的表达。与 FCS 培养基相比,HS 和 X15 培养基获得的细胞系更多(分别为 7/10、5/10 和 4/10)。建立稳定细胞系的时间在三种培养基中相似。从同一种肿瘤样本来源的细胞在不同培养基中观察到的形态差异不大。使用 X15 培养基,细胞通常表达较低水平的黑色素细胞分化抗原和表面分子。在无 FCS 培养介质中生长黑色素瘤细胞系是可能的,并且具有增加获得自体肿瘤细胞系的可能性。此外,获得的细胞可作为主动或过继免疫疗法方案中的多种抗原来源使用。

相似文献

引用本文的文献

9
Tissue biomarkers in melanoma patients treated with TIL.TIL 治疗的黑色素瘤患者的组织生物标志物。
PLoS One. 2012;7(12):e48729. doi: 10.1371/journal.pone.0048729. Epub 2012 Dec 20.

本文引用的文献

4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验